Responses to pomalidomide and placebo in myelofibrosis-related anaemia.

Authors	D M Ross
Journal	Leukemia (Leukemia) Vol. 31 Issue 3 Pg. 532-533 (03 2017) ISSN: 1476-5551 [Electronic] England
PMID	27932792 (Publication Type: Editorial)
Chemical References	Immunologic Factors Thalidomide pomalidomide
Topics	Anemia (complications, drug therapy) Humans Immunologic Factors Primary Myelofibrosis (complications) Thalidomide (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!